Wells Fargo’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$142K Sell
5,117
-15,315
-75% -$424K ﹤0.01% 4581
2025
Q1
$454K Sell
20,432
-670
-3% -$14.9K ﹤0.01% 3744
2024
Q4
$417K Buy
21,102
+7,463
+55% +$148K ﹤0.01% 3846
2024
Q3
$341K Sell
13,639
-494
-3% -$12.3K ﹤0.01% 3861
2024
Q2
$264K Buy
14,133
+1,574
+13% +$29.4K ﹤0.01% 3977
2024
Q1
$248K Buy
12,559
+1,964
+19% +$38.8K ﹤0.01% 3974
2023
Q4
$186K Sell
10,595
-23,377
-69% -$410K ﹤0.01% 4117
2023
Q3
$590K Buy
33,972
+1,019
+3% +$17.7K ﹤0.01% 3396
2023
Q2
$464K Buy
32,953
+3,071
+10% +$43.2K ﹤0.01% 3792
2023
Q1
$322K Buy
29,882
+28,988
+3,243% +$312K ﹤0.01% 3887
2022
Q4
$13.4K Sell
894
-323
-27% -$4.84K ﹤0.01% 5110
2022
Q3
$16K Sell
1,217
-315
-21% -$4.14K ﹤0.01% 5177
2022
Q2
$15K Sell
1,532
-2,362
-61% -$23.1K ﹤0.01% 5295
2022
Q1
$39K Sell
3,894
-10,229
-72% -$102K ﹤0.01% 5433
2021
Q4
$166K Sell
14,123
-4,802
-25% -$56.4K ﹤0.01% 4992
2021
Q3
$216K Sell
18,925
-13,711
-42% -$156K ﹤0.01% 4782
2021
Q2
$455K Sell
32,636
-87,057
-73% -$1.21M ﹤0.01% 4396
2021
Q1
$2.22M Buy
119,693
+47,478
+66% +$879K ﹤0.01% 3400
2020
Q4
$1.28M Buy
72,215
+22,812
+46% +$403K ﹤0.01% 3781
2020
Q3
$756K Buy
49,403
+9,217
+23% +$141K ﹤0.01% 3974
2020
Q2
$1.02M Buy
40,186
+30,496
+315% +$777K ﹤0.01% 3710
2020
Q1
$150K Buy
9,690
+1,862
+24% +$28.8K ﹤0.01% 4674
2019
Q4
$86K Buy
7,828
+7
+0.1% +$77 ﹤0.01% 5132
2019
Q3
$66K Buy
7,821
+513
+7% +$4.33K ﹤0.01% 5208
2019
Q2
$99K Sell
7,308
-6,220
-46% -$84.3K ﹤0.01% 5083
2019
Q1
$244K Buy
13,528
+3,787
+39% +$68.3K ﹤0.01% 4653
2018
Q4
$273K Buy
9,741
+8,824
+962% +$247K ﹤0.01% 4561
2018
Q3
$23K Buy
+917
New +$23K ﹤0.01% 5458